BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7789072)

  • 21. Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy.
    Vogl TJ; Mack MG; Balzer JO; Engelmann K; Straub R; Eichler K; Woitaschek D; Zangos S
    Radiology; 2003 Nov; 229(2):457-64. PubMed ID: 14500854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of local lipiodol chemoembolization therapy in primary and secondary hepatic tumors].
    András C; Szúcs Farkas Z; Csiki Z; Gál I; Takács I; Sápy P; Péter M
    Orv Hetil; 2000 Aug; 141(32):1773-7. PubMed ID: 10979306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
    Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO
    J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antiblastic hypoxic stop-flow perfusion in the treatment of liver metastasis: preliminary results].
    Roversi R; Cavallo G; Ricci S; Rossi G; Roversi M; Fiorentini G
    Radiol Med; 1997 Apr; 93(4):410-7. PubMed ID: 9244920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?
    Maire F; Hammel P; Kianmanesh R; Hentic O; Couvelard A; Rebours V; Zappa M; Raymond E; Sauvanet A; Louvet C; Lévy P; Belghiti J; Ruszniewski P
    Surgery; 2009 Jan; 145(1):69-75. PubMed ID: 19081477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repetitive transarterial chemoembolization (TACE) of liver metastases from gastric cancer: local control and survival results.
    Vogl TJ; Gruber-Rouh T; Eichler K; Nour-Eldin NE; Trojan J; Zangos S; Naguib NN
    Eur J Radiol; 2013 Feb; 82(2):258-63. PubMed ID: 23127803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic arterial infusion (HAI) of cisplatin and systemic fluorouracil in the treatment of unresectable colorectal liver metastases.
    Mancini R; Tedesco M; Garufi C; Filippini A; Arcieri S; Caterino M; Pizzi G; Cortesi E; Spila A; Sperduti I; Cosimelli M
    Anticancer Res; 2003; 23(2C):1837-41. PubMed ID: 12820466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcatheter arterial chemotherapy using miriplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Imai N; Ikeda K; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Jpn J Clin Oncol; 2012 Mar; 42(3):175-82. PubMed ID: 22210921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Liver abscess formation after treatment of liver cancer by arterial injection using adriamycin/mitomycin C oil suspension (ADMOS)].
    Inoue H; Hori A; Satake M; Kanetsuki I; Ueno K; Nishida H; Ikeda K; Kobayashi H; Nakajo M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Feb; 52(2):155-63. PubMed ID: 1313961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
    Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases.
    Neyns B; Aerts M; Van Nieuwenhove Y; Fontaine C; De Coster L; Schallier D; Vanderauwera J; De Munck F; Vandenbroucke F; Everaert H; Meert V; De Mey J; De Ridder M; Delvaux G; De Grève J
    Anticancer Res; 2008; 28(4C):2459-67. PubMed ID: 18751435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoembolization of hepatocellular carcinoma: patient status at presentation and outcome over 15 years at a single center.
    Brown DB; Chapman WC; Cook RD; Kerr JR; Gould JE; Pilgram TK; Darcy MD
    AJR Am J Roentgenol; 2008 Mar; 190(3):608-15. PubMed ID: 18287429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
    Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization.
    Homma H; Doi T; Mezawa S; Takada K; Kukitsu T; Oku T; Akiyama T; Kusakabe T; Miyanishi K; Niitsu Y
    Cancer; 2000 Jul; 89(2):303-13. PubMed ID: 10918160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
    Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D
    Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatic arterial infusion chemotherapy and embolization in the treatment of hepatic carcinoma].
    Wang ZY; Shi ZH; Zai RY
    Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):454-7. PubMed ID: 7720505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
    AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Transcatheter arterial chemoembolization and selective hepatic arterial infusion using totally implantable reservoir].
    Sakurai Y; Kodaira S; Teramoto T; Miyajima N; Kuzuoka M; Ishii T; Arisawa Y; Takabayashi T; Abe O
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2473-8. PubMed ID: 3415258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.